| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5581023 | Clinical Genitourinary Cancer | 2017 | 11 Pages |
Abstract
The Decipher GC could be a cost-effective approach for genomics-driven cancer treatment decisions after prostatectomy, with improvements in estimated clinical outcomes compared with usual care. The individualized decision analytic framework applied in the present study offers a flexible approach to estimate the potential utility of genomic assays for personalized cancer medicine.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Jennifer M. Lobo, Daniel M. Trifiletti, Vanessa N. Sturz, Adam P. Dicker, Christine Buerki, Elai Davicioni, Matthew R. Cooperberg, R. Jeffrey Karnes, Robert B. Jenkins, Robert B. Den, Timothy N. Showalter,